News

Medscape2h
EMA: Varicella Vaccines to Warn of Rare Encephalitis Risk
The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa ...
Medscape3h
EU to Ease Clozapine Monitoring Frequency After First Year
Clozapine blood monitoring can now be reduced to every 12 weeks after 1 year of treatment, and annually after 2 years, in patients without neutropenia.
Europe lifts restriction on Valneva's chikungunya vaccine for elderly adults
The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...
Novo Nordisk submits higher Wegovy dose to the European Medicines Agency for approval
Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...
The Manila Times3d
Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly
July, 11 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating ...
Covington Hires Top Litigator from European Medicines Agency
The server encountered an error and could not complete your request. If the problem persists, please contact us using the ...
Pharmabiz3d
Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane
Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...